Careers  |   Log In  |   Register  |   Welcome Center  |   Follow Us  Facebook  Twitter Google Plus
 
Course List


  • CME Information

Title:

Diabetes Full Circle: Digesting New Data on Combination Therapy and
Cardiovascular Risk

  1. Interview #1 - Digesting New Guidelines: Are They a Game Changer for Treating Diabetes
    and More?
  2. Interview #2 - Digesting New Data: Combination SGLT2 Inhibitors with DPP-4 Inhibitors
  3. Interview #3 - Digesting New Data in T2DM: Improving CV Risk

Provider Statement

This continuing medical education activity is jointly provided by Vindico Medical Education and American Osteopathic Association.

Support Statement

This activity is supported by an independent educational grant from Boehringer-Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.

Activity Chair and AOA Reviewer:

Jeffrey S. Freeman, DO, FACOI
Professor of Internal Medicine
Chairman
Division of Endocrinology and Metabolism
Philadelphia College of Osteopathic Medicine
Philadelphia, PA

Disclosures:

No relevant financial relationships to disclose.

Faculty:

Scott V. Joy, MD, MBA, FACP, FACOI
Medical Director
Uptown Primary Care
Professor of Clinical Practice University of Colorado
Denver, CO

Disclosures:

Consulting Fees: AstraZeneca, Boehringer-Ingelheim, Eli Lilly, Exact Sciences, Janssen, Novo Nordisk

Craig W. Spellman, DO, PhD, FACOI
Professor of Medicine
Texas Tech University Health Sciences Center
Director
Medical Center Hospital Diabetes Center
Odessa, TX

Disclosures:

No relevant financial relationships to disclose.

External Reviewer:

Ronald Codario, Jr., MD
No relevant financial relationships to disclose.

Vindico Medical Education and the American Osteopathic Association (AOA) staff report the following relationship(s):

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance and the American Osteopathic Association CME Department.

Disclosures

In accordance with the Accreditation Council for Continuing Medical Education and the American Osteopathic Association (AOA) Council on Continuing Education's Standards for Commercial Support, all planners, teachers, authors, and reviewers involved in the development of CME content are required to disclose to the accredited provider their relevant financial relationships. Relevant financial relationships will be disclosed to the activity audience prior to viewing content.

Accreditation

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Vindico Medical Education and American Osteopathic Association. Vindico Medical Education is accredited by the ACCME to provide continuing medical education for physicians.

This activity has been planned and implemented in accordance with the American Osteopathic Association (AOA) Accreditation requirements and policies of the AOA Council for Continuing Medical Education.

Target Audience

The intended audience for the activity is family physicians, endocrinologists, osteopathic physicians and other health care professionals involved in the treatment of patients with type 2 diabetes mellitus (T2DM).

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™, 0.25 credits per video. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The American Osteopathic Association (AOA) Council on Continuing Medical Education has designated this webcast for 0.75 Category 1-B AOA Credits, 0.25 credits per video.

Program ID: 264680

This enduring material is approved for 1 year from the date of original release, April 19, 2016 to April 18, 2017.

How To Participate in this Activity and Obtain CME Credit

To participate in this CME activity per video, you must read the objectives, answer the pretest questions, watch the presentations, complete the CME posttests, and then fill in the evaluations. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 2 out of 3 of the posttest questions correctly for each video. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate or the American Osteopathic Association will issue a Category 1-B AOA Credits Certificate.

Overview

The prevalence of diabetes continues to increase. It is therefore necessary for physicians to have knowledge of current recommendations for glycemic goals, and to apply the treatment algorithms published by the American Diabetes Association (ADA)/European Association for the Study of Diabetes (EASD), and the American Association of Clinical Endocrinologists (AACE)/American College of Endocrinology (ACE) in the management of patients afflicted with type 2 diabetes mellitus (T2DM). With the increasing number of anti-diabetic agents and newly released data about their safe and effective combined use, osteopathic family physicians, internists, endocrinologists and other health care professionals involved in the treatment of patients with T2DM will rely on continuing medical education (CME) to assist them in clinical decision making that will ultimately improve the health of their patients. This CME and American Osteopathic Association (AOA) activity will feature interviews with clinical experts, who will discuss newly released evidence and guidelines regarding glycemic management in patients with T2DM, new findings about incretin-based therapy and sodium glucose co-transporter 2 (SGLT2) inhibitors, and evidence for the use of combined SGLT2/DPP-4 inhibitor therapy to improve glycemic control and other cardiovascular risk factors in patients with T2DM.

Learning Objectives

Upon successful completion of this educational series, participants should be better able to:

  • Apply newly released evidence and guidelines to practice regarding glycemic management in patients with type 2 diabetes.
  • Include new findings about incretin-based therapy and sodium glucose co-transporter 2 inhibitors into management strategies for patients with diabetes.
  • Assess the evidence for the use of combined SGLT2/DPP-4 inhibitor therapy to improve glycemic control and other cardiovascular risk factors in patients with type 2 diabetes.

Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2016 Vindico Medical Education. All rights reserved.

No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education and the American Osteopathic Association continuing education activities does not necessarily reflect the views and opinions of Vindico Medical Education and the American Osteopathic Association. Neither Vindico Medical Education nor the American Osteopathic Association, nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

Educational Tools:

For downloadable handouts, patient education tools, and online resources for your clinical practice provided by Vindico Medical Education, please visit: www.VindicoCME.com/EducationalTools.

CME Questions?

Contact us at cme@vindicocme.com or 856-994-9400, ext 504.
American Osteopathic Association: crc@osteopathic.org or 800-621-1773, ext. 8262.